Sgltr-V Tablet

PRODUCT INTRODUCTION

Sgltr-V Tablet is a prescription medication primarily utilized in the management of type 2 diabetes mellitus. This oral hypoglycemic agent belongs to a class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors, which work by helping the kidneys to lower blood sugar levels. The main ingredient in Sgltr-V Tablet is a potent SGLT2 inhibitor that aids in controlling high blood sugar levels, thereby preventing serious complications of diabetes such as nerve damage, kidney damage, blindness, and loss of limbs.

Manufactured following stringent quality controls, Sgltr-V Tablet ensures safety and efficacy for diabetic patients. It is usually prescribed as part of a comprehensive treatment plan that includes diet, exercise, and sometimes other medications to achieve optimal blood sugar control. The tablet is typically taken once daily, with or without food, as directed by a healthcare professional.

USES OF Sgltr-V TABLET

Sgltr-V Tablet is primarily used for the treatment of type 2 diabetes mellitus. It helps in:

1. Blood Sugar Control: By preventing the kidneys from reabsorbing glucose back into the blood, Sgltr-V Tablet allows excess glucose to be excreted through urine. This mechanism significantly lowers blood sugar levels in people with type 2 diabetes.
2. Weight Management: One of the beneficial side effects of Sgltr-V Tablet is modest weight loss. Since it works by excreting excess glucose, which contains calories, patients often experience a reduction in body weight.
3. Cardiovascular Benefits: Sgltr-V Tablet has been shown to reduce the risk of heart failure and other cardiovascular events in diabetic patients. This benefit makes it a valuable choice for patients with both diabetes and heart disease.
4. Renal Protection: By lowering blood sugar levels and blood pressure, Sgltr-V Tablet helps protect the kidneys from damage, a common complication in diabetes.

BENEFITS OF Sgltr-V TABLET

The Sgltr-V Tablet offers several significant benefits to patients with type 2 diabetes:

1. Effective Blood Sugar Control: Sgltr-V Tablet effectively lowers blood sugar levels, helping to maintain them within the target range and reducing the risk of hyperglycemia.
2. Weight Loss: Unlike some diabetes medications that cause weight gain, Sgltr-V Tablet is associated with weight loss, which can be beneficial for overweight or obese patients with type 2 diabetes.
3. Cardiovascular Protection: Studies have shown that Sgltr-V Tablet can reduce the risk of major adverse cardiovascular events, including heart attack and stroke, making it a good option for diabetic patients with an elevated cardiovascular risk.
4. Kidney Health: Sgltr-V Tablet helps in maintaining kidney function by reducing the strain on the kidneys through improved blood sugar and blood pressure control.
5. Reduced Blood Pressure: Besides lowering blood sugar levels, Sgltr-V Tablet also helps in reducing systolic blood pressure, which is advantageous for patients with hypertension and diabetes.
6. Low Risk of Hypoglycemia: When used alone, Sgltr-V Tablet has a low risk of causing hypoglycemia (low blood sugar levels) compared to other diabetes medications, particularly insulin and sulfonylureas.

SIDE EFFECTS OF Sgltr-V TABLET

While Sgltr-V Tablet is generally well-tolerated, it may cause some side effects. Not all patients will experience these, but it is essential to be aware of the potential risks:

1. Genital Infections: Due to the increased excretion of glucose in urine, there is a higher risk of developing genital yeast infections in both men and women.
2. Urinary Tract Infections (UTIs): The presence of glucose in the urine can also increase the likelihood of urinary tract infections.
3. Increased Urination: As Sgltr-V Tablet works by promoting the excretion of glucose through urine, it may cause increased urination, which could lead to dehydration if fluid intake is not adequately maintained.
4. Dizziness or Lightheadedness: Some patients might experience dizziness or lightheadedness, particularly when standing up quickly, due to the diuretic effect of the medication which can lead to a drop in blood pressure.
5. Ketoacidosis: Although rare, Sgltr-V Tablet can increase the risk of diabetic ketoacidosis, a serious condition characterized by high levels of ketones in the blood.
6. Renal Impairment: In rare cases, the medication may lead to reduced kidney function, necessitating regular monitoring of renal parameters.
7. Hypoglycemia: While the risk is low, combining Sgltr-V Tablet with other glucose-lowering medications, such as insulin, may increase the likelihood of hypoglycemia.